# Citalopram for Agitation in Alzheimer's Disease

> **NCT00898807** · PHASE3 · COMPLETED · sponsor: **JHSPH Center for Clinical Trials** · enrollment: 186 (actual)

## Conditions studied

- Alzheimer's Disease
- Agitation

## Interventions

- **DRUG:** citalopram
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00898807
- **Lead sponsor:** JHSPH Center for Clinical Trials
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2014-06-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00898807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00898807, "Citalopram for Agitation in Alzheimer's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00898807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*